NFKB1 and rheumatoid arthritis: These results indicated that SKLB023 not only affected the binding activity of NF-κB to DNA, also the expression of proteins related with NF-κB signaling pathways in RA, which warrant the amelioration of SKLB023 on the RA and other inflammatory diseases.